Home/Filings/4/0001516551-23-000010
4//SEC Filing

Ward Keith Wayne 4

Accession 0001516551-23-000010

CIK 0001516551other

Filed

Jan 8, 7:00 PM ET

Accepted

Jan 9, 10:42 AM ET

Size

5.6 KB

Accession

0001516551-23-000010

Insider Transaction Report

Form 4
Period: 2023-01-05
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-01-05+250,000250,000 total
    Exercise: $0.02Exp: 2033-01-05Common Stock (250,000 underlying)
Footnotes (1)
  • [F1]The option grant shall be exercisable for a price of $0.017 per option share for ten years from January 5, 2023 and the options will vest in equal monthly installments over the one year period beginning December 8, 2022.

Issuer

Skye Bioscience, Inc.

CIK 0001516551

Entity typeother

Related Parties

1
  • filerCIK 0001662394

Filing Metadata

Form type
4
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 10:42 AM ET
Size
5.6 KB